_version_ 1783310315659722752
author Goudouris, Ekaterini Simões
Silva, Almerinda Maria do Rego
Ouricuri, Aluce Loureiro
Grumach, Anete Sevciovic
Condino-Neto, Antonio
Costa-Carvalho, Beatriz Tavares
Prando, Carolina Cardoso de Mello
Kokron, Cristina Maria
Vasconcelos, Dewton de Moraes
Tavares, Fabíola Scancetti
Segundo, Gesmar Rodrigues Silva
Barreto, Irma Cecília Douglas Paes
Dorna, Mayra de Barros
Barros, Myrthes Anna Maragna Toledo
Forte, Wilma Carvalho Neves
author_facet Goudouris, Ekaterini Simões
Silva, Almerinda Maria do Rego
Ouricuri, Aluce Loureiro
Grumach, Anete Sevciovic
Condino-Neto, Antonio
Costa-Carvalho, Beatriz Tavares
Prando, Carolina Cardoso de Mello
Kokron, Cristina Maria
Vasconcelos, Dewton de Moraes
Tavares, Fabíola Scancetti
Segundo, Gesmar Rodrigues Silva
Barreto, Irma Cecília Douglas Paes
Dorna, Mayra de Barros
Barros, Myrthes Anna Maragna Toledo
Forte, Wilma Carvalho Neves
author_sort Goudouris, Ekaterini Simões
collection PubMed
description
format Online
Article
Text
id pubmed-5875174
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format MEDLINE/PubMed
spelling pubmed-58751742018-03-30 Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16 Goudouris, Ekaterini Simões Silva, Almerinda Maria do Rego Ouricuri, Aluce Loureiro Grumach, Anete Sevciovic Condino-Neto, Antonio Costa-Carvalho, Beatriz Tavares Prando, Carolina Cardoso de Mello Kokron, Cristina Maria Vasconcelos, Dewton de Moraes Tavares, Fabíola Scancetti Segundo, Gesmar Rodrigues Silva Barreto, Irma Cecília Douglas Paes Dorna, Mayra de Barros Barros, Myrthes Anna Maragna Toledo Forte, Wilma Carvalho Neves Einstein (Sao Paulo) Letter to the Editor Instituto Israelita de Ensino e Pesquisa Albert Einstein 2017 /pmc/articles/PMC5875174/ /pubmed/29364371 http://dx.doi.org/10.1590/S1679-45082017CE4250 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Goudouris, Ekaterini Simões
Silva, Almerinda Maria do Rego
Ouricuri, Aluce Loureiro
Grumach, Anete Sevciovic
Condino-Neto, Antonio
Costa-Carvalho, Beatriz Tavares
Prando, Carolina Cardoso de Mello
Kokron, Cristina Maria
Vasconcelos, Dewton de Moraes
Tavares, Fabíola Scancetti
Segundo, Gesmar Rodrigues Silva
Barreto, Irma Cecília Douglas Paes
Dorna, Mayra de Barros
Barros, Myrthes Anna Maragna Toledo
Forte, Wilma Carvalho Neves
Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
title Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
title_full Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
title_fullStr Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
title_full_unstemmed Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
title_short Comment to: II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (São Paulo). 2017;15(1):1-16
title_sort comment to: ii brazilian consensus on the use of human immunoglobulin in patients with primary immunodeficiencies. einstein (são paulo). 2017;15(1):1-16
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875174/
https://www.ncbi.nlm.nih.gov/pubmed/29364371
http://dx.doi.org/10.1590/S1679-45082017CE4250
work_keys_str_mv AT goudourisekaterinisimoes commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT silvaalmerindamariadorego commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT ouricurialuceloureiro commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT grumachanetesevciovic commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT condinonetoantonio commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT costacarvalhobeatriztavares commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT prandocarolinacardosodemello commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT kokroncristinamaria commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT vasconcelosdewtondemoraes commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT tavaresfabiolascancetti commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT segundogesmarrodriguessilva commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT barretoirmaceciliadouglaspaes commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT dornamayradebarros commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT barrosmyrthesannamaragnatoledo commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116
AT fortewilmacarvalhoneves commenttoiibrazilianconsensusontheuseofhumanimmunoglobulininpatientswithprimaryimmunodeficiencieseinsteinsaopaulo2017151116